Xiang Luo
Clinical trials sponsored by Xiang Luo, explained in plain language.
-
Stroke patients may benefit from simple heparin injection during brain scans
Disease control CompletedThis study tested whether giving a small dose of the blood thinner heparin during brain angiography can prevent the radial artery (in the wrist) from becoming blocked afterward. The trial included 440 adults with acute ischemic stroke who needed this procedure. Half received hepa…
Phase: PHASE3 • Sponsor: Xiang Luo • Aim: Disease control
Last updated Jun 24, 2026 11:06 UTC
-
Blood thinner after stroke surgery shows promise in large trial
Disease control CompletedThis study tested whether giving the blood-thinning drug tirofiban after mechanical clot removal improves outcomes in people with acute ischemic stroke. Over 1,300 participants were randomly assigned to receive tirofiban or a placebo. The goal was to see if tirofiban could reduce…
Phase: PHASE2, PHASE3 • Sponsor: Xiang Luo • Aim: Disease control
Last updated Jun 23, 2026 12:09 UTC
-
Stroke patients get powerful cholesterol drug combo within 48 hours – does it prevent brain decline?
Disease control CompletedThis study tested whether giving a strong cholesterol-lowering injection (evolocumab) plus standard statin pills within 48 hours of a stroke can prevent early worsening. 429 adults with moderate-to-severe artery narrowing in the brain took part. The goal was to see if the combo r…
Phase: PHASE2, PHASE3 • Sponsor: Xiang Luo • Aim: Disease control
Last updated Jun 12, 2026 12:04 UTC